ESR1 and breast carcinoma: It sensitizes the TNF signaling pathway to induce apoptosis and downregulate estrogen receptor expression in breast cancer (52), while also promoting cell proliferation and invasion in ovarian cancer (53), whereas its disruption in cervical and liver cancers fosters tumor progression (54, 55).